Leiden Jeffrey M's Form 4 filing
Vertex Pharmaceuticals Inc (VRTX) · filed May 4, 2023
- Accession no.
- 0001209191-23-027372
- Filed
- May 4, 2023
- Trade date
- May 2-3, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions. Open-market sales total $3.84M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Leiden Jeffrey MCIK 0001242825 | Director, Officer (Executive Chairman) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 2, 2023 | Common Stock | SSaleDisposed | −4,645 | $349.48F2,F3 | −$1,623,334.6 | 43,704 | Direct | |
| May 2, 2023 | Common Stock | SSaleDisposed | −1,505 | $350.48F2,F4 | −$527,472.4 | 42,199 | Direct | |
| May 2, 2023 | Common Stock | SSaleDisposed | −300 | $353.18F2,F5 | −$105,954 | 41,899 | Direct | |
| May 3, 2023 | Common Stock | SSaleDisposed | −2,008 | $349.22F2,F6 | −$701,233.76 | 39,891 | Direct | |
| May 3, 2023 | Common Stock | SSaleDisposed | −1,800 | $350.53F2,F7 | −$630,954 | 38,091 | Direct | |
| May 3, 2023 | Common Stock | SSaleDisposed | −700 | $351.59F2,F8 | −$246,113 | 37,391 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Referenced by the price of 6 transactions in Table I.
- F3
Open market sales reported on this line occurred at a weighted average price of $349.48 (range $349.00 to $349.99).
Referenced by the price of 1 transaction in Table I.
- F4
Open market sales reported on this line occurred at a weighted average price of $350.48 (range $350.08 to $351.01).
Referenced by the price of 1 transaction in Table I.
- F5
Open market sales reported on this line occurred at a weighted average price of $353.18 (range $352.63 to $353.53).
Referenced by the price of 1 transaction in Table I.
- F6
Open market sales reported on this line occurred at a weighted average price of $349.22 (range $349.00 to $349.94).
Referenced by the price of 1 transaction in Table I.
- F7
Open market sales reported on this line occurred at a weighted average price of $350.53 (range $350.08 to $350.90).
Referenced by the price of 1 transaction in Table I.
- F8
Open market sales reported on this line occurred at a weighted average price of $351.59 (range $351.33 to $352.02).
Referenced by the price of 1 transaction in Table I.